Short‐Term Hemodynamic and Neuroendocrine Effects of Pimobendan and Benazapril in Dogs with Myxomatous Mitral Valve Disease and Congestive Heart Failure
Conclusions and Clinical ImportancePimobendan improves short‐term cardiac function more than benazepril in dogs with CHF caused by MMVD. Pimobendan treatment enables the heart to work at smaller end‐systolic and diastolic dimensions while maintaining adequate forward stroke volume. Some of the treatment responses found in neuroendocrine profile might have therapeutic relevance.
Source: Journal of Veterinary Internal Medicine - Category: Veterinary Research Authors: J. Häggström, P.F. Lord, K. Höglund, I. Ljungvall, O. Jöns, C. Kvart, K. Hansson Tags: Original Article Source Type: research
More News: Benazepril | Cardiology | Congestive Heart Failure | Furosemide | Heart | Heart Failure | Hormones | Internal Medicine | Neurology | Radiography | Stroke | Study | Veterinary Research